Skip to main content

GH Research PLC

GHRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001855129

No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.

Members of Congress who traded GHRS

No member of Congress has reported a trade in GH Research PLC since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.